Skip to main content
. Author manuscript; available in PMC: 2017 Jan 3.
Published in final edited form as: Vaccine. 2016 Sep 26;34(46):5643–5648. doi: 10.1016/j.vaccine.2016.09.020

Table 3.

Public health programs planned weekly allocation of pandemic influenza vaccine, by provider type (n = 48).a

Provider type Proportion of pandemic vaccine to be allocated

Less than 5%,
No. (%)
Greater than or equal to 5%;
less than 10%, No. (%)
Greater than or equal to 10%;
less than 15%, No. (%)
Greater than or equal to 15%;
less than 20%, No. (%)
20% or
greater, No.
(%)
Mass vaccination
  clinics/points of
  dispensingb
13 (27.1%) 3 (6.3%) 3 (6.3%) 0 (0.0%) 29 (60.4%)
School-located vaccination
  clinics
26 (54.2%) 9 (18.8%) 7 (14.6%) 3 (6.3%) 3 (6.3%)
Vaccines for children
  providers
11 (22.9%) 0 (0.0%) 15 (31.3%) 6 (12.5%) 16 (33.3%)
Non-vaccines for children
  providersc
18 (37.5%) 9 (18.8%) 7 (14.6%) 6 (12.5%) 8 (16.7%)
Local health departments 16 (33.3%) 7 (14.6%) 4 (8.3%) 2 (4.2%) 19 (39.6%)
Retail-based clinicsd 34 (70.8%) 8 (16.7%) 4 (8.3%) 1 (2.1%) 1 (2.1%)
Large pharmaciesd 18 (37.5%) 7 (14.6%) 11 (22.9%) 4 (8.3%) 8 (16.7%)
Local pharmaciesd 32 (66.7%) 13 (27.1%) 2 (4.2%) 1 (2.1%) 0 (0.0%)

Data source: 2015 Pandemic Influenza Readiness Assessment (PIRA).

a

5 jurisdictions did not provide responses for any categories, and were omitted. Non-responses were coded as 0 when awardees reported intent to allocate to other providers.

b

Combined open and closed points of dispensing.

c

Combined non-VFC adult and pediatric providers.

d

All of these are considered community pharmacies, but were separated out in this manner for the PIRA questionnaire.